A focus on the asthma HEDIS measure and its implications for clinical practice

Managed Care Interface

Volumn 19, Issue 2, 2006, Pages 29-36

  Davies, Thomas J ^a   Bunn III, William B ^b,c   Fromer, Leonard ^d   Gelfand, Erwin W ^e   Colice, Gene L ^f,g  

^a Integrated Healthcare Association   (United States)

^b Navistar International Corporation   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^f GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^g WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CICLESONIDE; FLUTICASONE;

ARTICLE; ASTHMA; CLINICAL PRACTICE; DAILY LIFE ACTIVITY; DISEASE SEVERITY; EMERGENCY WARD; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH PLAN EMPLOYER DATA AND INFORMATION SET; HUMAN; MANAGED CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; PRACTICE GUIDELINE;

ASTHMA; BENCHMARKING; DISEASE MANAGEMENT; DRUG UTILIZATION REVIEW; EDUCATION, MEDICAL, CONTINUING; GUIDELINE ADHERENCE; HEALTH BENEFIT PLANS, EMPLOYEE; HUMANS; MANAGED CARE PROGRAMS; PATIENT EDUCATION; PHYSICIAN-PATIENT RELATIONS; PRACTICE GUIDELINES; QUALITY INDICATORS, HEALTH CARE; REIMBURSEMENT, INCENTIVE; UNITED STATES;

EID: 33644656847     PISSN: 10965645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Lopez G, Wyatt L: Asthma prevalence, barriers to effective treatment, and current policy recommendations for the State of California. California Research Bureau 2002 Educational Tour Series (www. library.ca.gov/crb/03/04/03-004.pdf), July 27, 2005.
2. Mannino DM, Homa DM, Akinbami LJ, et al: Surveillance for asthma-United States, 1980-1999. MMWA Surveill Summ 2002;51(1):1-13.
3. Trends in asthma morbidity and mortality. American Lung Association (www.lungusa.org/atf/cf/%7B7A8D42C2-FCCA-4604-8ADE-7F5D5E762256%7D/ASTHMA1.PDF), May 2005.
4. Asthma in America: An executive summary. Asthma in America (www. asthmainamerica.com/aaa_index.html), July 12, 2005.
5. Hemp P: Presenteeism: At work-but out of it. Harv Bus Rev 2004;82:49-58.
6. Davies TJ: Pay for performance: A business case for quality for California physician groups. Manag Care 2004;13(suppl 10):3-8.
7. Glendinning D: Medicare tests pay-for-performance: The AMA urges focus on quality improvement over cost control in the demonstration project. Amednews.com (www.ama-assn.org/amednews/2005/02/21/gvl10221.htm), February 21, 2005.
8. Sin DD, Man SF: Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch Intern Med 2002;162:1591-1595.
9. Stempel DA, Roberts CS, Stanford RH: Treatment patterns in the months prior to and after asthma-related emergency department visit. Chest 2004;126:75-80.
10. Doerschug KC, Peterson MW, Dayton CS, et al: Asthma guidelines: An assessment of physician understanding and practice. Am J Respir Crit Care Med 1999;159:1735-1741.
11. Cabana MD, Rand CS, Powe NR, et al: Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-1465.
12. Wolfenden LL, Diette GB, Krishnan JA, et al: Lower physician estimate of underlying asthma severity leads to undertreatment. Arch Intern Med 2003;163: 231-236.
13. Baker KM, Brand DA, Hen Jr J: Classifying asthma: Disagreement among specialists. Chest 2003;124:2156-2163.
14. Woodwell DA, Cherry DK: Advance Data From Vital and Health Statistics. National Ambulatory Medical Care Survey: 2002 Summary (www.cdc.gov/nchs/data/ad/ ad346.pdf), September 28, 2005.
15. Bousquet J, Jeffery PK, Busse WW, et al: Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-1745.
16. Green RH, Brightling CE, McKenna S, et al: Asthma exacerbations and sputum eosinophil counts: A randomised controlled trial. Lancet 2002;360:1715-1721.
17. Rosias PP, Dompeling E, Dentener MA, et al: Childhood asthma: Exhaled markers of airway inflammation, asthma control score, and lung function tests. Pediatr Pulmonol 2004;38:107-114.
18. Sont JK, Willems LN, Bel EH, et al: Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999;159:1043-1051.
19. Colice GL, Vanden Burgt J, Song J, et al: Categorizing asthma severity. Am J Respir Crit Care Med 1999;160:1962-1967.
20. Allen DB, Bielory L, Derendorf H, et al: Inhaled corticosteroids: Past lessons and future issues. J Allergy Clin Immunol 2003;112(suppl 3):1-40.
21. Roland NJ, Bhalla RK, Earis J: The local side effects of inhaled corticosteroids: Current understanding and review of the literature. Chest 2004;126:213-219.
22. Physicians, business, government & industry embrace common strategy to improve health care: Pay-for-performance. National Committee for Quality Assurance (www.ncqa.org/communications/news/BTE_P4P2005.htm), March 18, 2005.
23. Overview, in: HEDIS 2004 Technical Specifications, vol 2. Washington, DC, National Committee for Quality Assurance, 2003; 11-17.
24. New online NCQA reports show how well health plans treat key illnesses. National Committee for Quality Assurance (www.ncqa.org/communications/news/lwir. htm), September 28, 2005.
25. Use of appropriate medications for people with asthma, in: HEDIS 2004 Technical Specifications, vol 2. Washington, DC, National Committee for Quality Assurance, 2003; 126-129.
26. National Asthma Education and Prevention Program. Expert Panel Report 2. Guidelines for the Diagnosis and Management of Asthma. Update on Selected Topics 2002. National Institutes of Health publication No. 97-4051, Bethesda, MD, National Heart, Lung, and Blood Institute, 1997.
27. Berger WE, Legorreta AP, Blaiss MS, et al: The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. Ann Allergy Asthma Immunol 2004;93:538-545.
28. Pay for performance: A business case for rewarding physician group excellence. Integrated Healthcare Association (www.iha.org/payfpov1.htm), July 12, 2005.
29. Burton WN, Connerty CM, Schultz AB, et al: Bank One's worksite-based asthma disease management program. J Occup Environ Med 2001;43:75-82.
30. Marshik PL: Pharmacologic treatment of pediatric asthma. Consider disease severity as well as delivery method. Adv Nurse Pract 2004;12:35-36, 41-46.
31. Buhl R, Vinkler I, Magyar P, et al: Once daily ciclesonide is as effective as fluticasone propionate given twice daily in treating patients with asthma. Presented at the 100th international conference of the American Thoracic Society. Orlando, May 21-26, 2004.
32. Christie P: Ciclesonide: A novel inhaled corticosteroid for asthma. Drugs Today 2004;40:569-576.
33. Nathan RA, Nayak AS, Graft DF, et al: Mometasone furoate: Efficacy and safety in moderate asthma compared with beclomethasone dipropionate. Ann Allergy Asthma Immunol 2001;86:203-210.